InsidersTradesSigma
Total declarations
Companies
▲ Purchases (3 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by Fairmount Funds Management LLC. Officer active across 2 companies, notably Viridian Therapeutics, Inc.\DE. In total, 3 disclosures have been published. Total volume traded: €26.4m. The latest transaction was filed on 16 June 2022 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations3 total
€9m1,200,000 shares@ €7.82220.17% mcap100.0% of flow
Common Stock
SEC:0001104659-22-072798:0·
Ideal exit: 13 Mar 2023 (T+270)
€9m909,000 shares@ €9.38330.49% mcap100.0% of flow
Common Stock
SEC:0000899243-21-037255·
Ideal exit: 18 Jun 2022 (T+270)
€9m909,000 shares@ €9.38330.49% mcap50.0% of flow
Common Stock
SEC:0000899243-21-037255:0·
Ideal exit: 18 Jun 2022 (T+270)
3 of 3 declarations
